Hong Kong Commercial Services Stock News

SEHK:883
SEHK:883Oil and Gas

CNOOC (SEHK:883) Margin Slippage Challenges Bullish Earnings Growth Narrative

CNOOC (SEHK:883) has wrapped up FY 2025 with fourth quarter revenue of CNY 85.7b and basic EPS of CNY 0.43, alongside net income of CNY 20.1b. This sits against a trailing twelve month picture that includes revenue of CNY 398.2b and EPS of CNY 2.57. Over recent periods, revenue has ranged from CNY 106.9b in the first quarter of 2025 to CNY 85.7b in the fourth quarter, while quarterly EPS moved between CNY 0.77 and CNY 0.43. This gives investors a clear view of how the top and bottom lines...
SEHK:2157
SEHK:2157Biotechs

Assessing Lepu Biopharma (SEHK:2157) Valuation After Its Earnings Turnaround And Recent Share Price Strength

Lepu Biopharma (SEHK:2157) just reported full year 2025 earnings, with sales of CN¥934.87 million and net income of CN¥261.36 million, compared with a net loss a year earlier. See our latest analysis for Lepu Biopharma. The earnings swing appears to be feeding into sentiment, with the HK$5.6 share price sitting after an 8.74% 1 day share price return, a 22.81% 30 day share price return and a 46.98% 1 year total shareholder return. This suggests that momentum has been building recently. If...
SEHK:6633
SEHK:6633Entertainment

Qingci Games (SEHK:6633) One Off Gain Drives 26.7% Margin And Tests Bullish Narratives

Qingci Games FY 2025 Earnings Snapshot Qingci Games (SEHK:6633) has reported FY 2025 results with first half revenue of CN¥247.18 million and basic EPS of CN¥0.10, while trailing twelve month EPS stands at CN¥0.18 as the business returns to profitability. Over recent periods the company has seen revenue move from CN¥342.62 million in 1H FY 2024 to CN¥285.34 million in 2H FY 2024 and CN¥247.18 million in 1H FY 2025, alongside net income shifting from CN¥45.06 million to CN¥6.06 million and...
SEHK:1099
SEHK:1099Healthcare

A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement

Sinopharm Group (SEHK:1099) has drawn investor attention after its board proposed a final dividend of CN¥0.69 per share for 2025, totaling about CN¥2.15b, subject to approval at the June 18 AGM. See our latest analysis for Sinopharm Group. The proposed dividend comes after a period where momentum has been mixed, with a 30 day share price return showing a decline of 7.38% and a one year total shareholder return of 15.09%. This suggests recent weakness against a stronger longer term outcome. If...
SEHK:100
SEHK:100Software

Assessing MiniMax Group’s Valuation After Strong Recent Share Price Momentum

MiniMax Group’s recent trading move and business snapshot MiniMax Group (SEHK:100) has drawn attention after a recent share price move, with a month return of 31.39% and 1 day and 7 day returns of 0.41% and 1.88% decline respectively. The company, founded in 2022 and based in George Town, Cayman Islands, designs and develops an artificial intelligence foundation model across text, audio, images, video, and music. See our latest analysis for MiniMax Group. MiniMax Group’s recent momentum is...
SEHK:86
SEHK:86Consumer Finance

Assessing Sun Hung Kai (SEHK:86) Valuation After Strong 2025 Earnings And Higher Dividend

Sun Hung Kai (SEHK:86) has drawn fresh attention after reporting full year 2025 results, with revenue of HK$5,473.6 million, net income of HK$1,593.1 million and a higher total dividend compared with 2024. See our latest analysis for Sun Hung Kai. At a share price of HK$4.25, Sun Hung Kai has seen a 6.52% 90 day share price return and a 45.33% 1 year total shareholder return, which may indicate momentum around the stronger earnings and higher dividend announcement. If the earnings story here...
SEHK:1810
SEHK:1810Tech

Assessing Whether Xiaomi (SEHK:1810) Looks Undervalued After A Mixed Recent Share Price Run

Assessing Xiaomi after a mixed share price run Xiaomi (SEHK:1810) has drawn fresh attention after a mixed share price stretch, with a 1.7% gain over the past day set against declines over the month and past 3 months. See our latest analysis for Xiaomi. Set against a 1-year total shareholder return decline of 35.36% and a 3-year total shareholder return above 170%, the recent negative 3-month share price return suggests momentum has cooled after a much stronger earlier period. If Xiaomi has...
SEHK:9926
SEHK:9926Biotechs

Akeso (SEHK:9926) FY 2025 Loss Deepens Despite 2H Revenue Growth Challenging Bullish Narratives

Akeso (SEHK:9926) has reported FY 2025 results with second half revenue of C¥1.6b and a basic EPS loss of C¥0.60, while trailing 12 month revenue reached C¥3.1b against a net loss of C¥1.1b. The business has seen revenue move from C¥1.1b in 2H 2024 to C¥1.6b in 2H 2025, with basic EPS shifting from a loss of C¥0.32 to a loss of C¥0.60 over the same period, as investors weigh growth in the top line against persistent losses. Overall, the latest numbers point to expanding operations but...
SEHK:1357
SEHK:1357Interactive Media and Services

Meitu (SEHK:1357) Net Margin Jump To 25.4% Tests Bullish AI Earnings Narrative

Meitu (SEHK:1357) has just posted its FY 2025 first half scorecard, with revenue of CN¥1.8b and basic EPS of CN¥0.09, against a backdrop of trailing twelve month revenue of CN¥3.5b and EPS of CN¥0.20 that coincides with earnings growth of 97.9% over the past year. The company has seen revenue move from CN¥1.6b and EPS of CN¥0.07 in 1H 2024 to CN¥1.8b and EPS of CN¥0.09 in 1H 2025, while trailing net profit margin sits at 25.4% versus 14.9% a year earlier and sets up a margin story that...